Communiqués IRIDEX Corporation

Actions

IRIX

US4626841013

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 13/07/2026			Varia. 5j.	Varia. 1 janv.
1,070 ^USD	-2,73%		-4,46%	-6,14%

19/05	Transcript : IRIDEX Corporation, Q1 2026 Earnings Call, May 19, 2026
19/05	IRIDEX Corporation publie ses résultats pour le premier trimestre clos le 4 avril 2026	CI

Communiqués

09/06	Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference	GL
19/05	IRIDEX : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q)	PU
19/05	Iridex: Q1 Earnings Snapshot	AQ
19/05	Iridex Reports First Quarter 2026 Financial Results	GL
05/05	Iridex to Report First Quarter 2026 Financial Results on May 19, 2026	GL
07/04	Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology	GL
02/04	IRIDEX : Annual Report for Fiscal Year Ending January 3, 2026 (Form 10-K)	PU
26/03	Iridex: Q4 Earnings Snapshot	AQ
26/03	Iridex Reports Fourth Quarter and Full Year 2025 Financial Results	GL
12/03	Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026	GL
02/02	Iridex Announces Plans to Relocate Headquarters	GL
02/02	Iridex Announces Plans to Relocate Headquarters	AQ
12/01	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025	GL
11/12	Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management	GL
08/12	Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment	GL
05/12	Iridex to Present at the Sidoti Year-End Virtual Investor Conference	GL
11/11	Iridex: Q3 Earnings Snapshot	AQ
11/11	Iridex Reports Third Quarter 2025 Financial Results	GL
28/10/25	Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025	GL
09/09/25	Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance	GL
12/08/25	Iridex: Q2 Earnings Snapshot	AQ
12/08/25	Iridex Reports Second Quarter 2025 Financial Results	GL
29/07/25	Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025	GL
24/06/25	Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema	GL
13/05/25	Iridex: Q1 Earnings Snapshot	AQ